A. Post-hoc analysis of the ALLHAT trial demonstrated that amlodipine, lisinopril, and chlorthalidone had similar efficacy in preventing cardiovascular events.1,2
B. In ALLHAT, lisinopril and chlorthalidone were comparable in preventing heart failure.1,2
C. In the SCOPE Trial, (elderly patients), when candesartan was compared to placebo for treatment of hypertension, there was no difference in the incidence of major cardiovascular events.1,3
D. In the Second Australian Blood Pressure (ANBP2) trial, (patients aged 65-84 years with hypertension) when ACEIs were compared to diuretics, ACEIs were superior in preventing cardiovascular events or deaths....